Drug intelligence / Profile preview

lallemantia royleana polysaccharide

Development stage
Preclinical
Administration
Oral
01

Overview

Lallemantia royleana polysaccharide is a high-molecular-weight water-soluble polysaccharide obtained from the seeds of the Lallemantia royleana plant, known for its traditional medicinal use in Iran and surrounding regions. The polysaccharide is primarily composed of arabinose, galactose, and rhamnose, with minor components including xylose and glucose. It has demonstrated hypocholesterolemic (lipid-lowering), antioxidant, and antimicrobial activities in preclinical models. The mechanism of action is believed to involve antioxidant properties and modification of lipid metabolism, though exact molecular targets remain undetermined. Studies indicate potential as a functional food component for cardiovascular and metabolic disease prevention, but it is not a registered pharmaceutical. Research is preclinical, focusing on animal models.

Other names
Lallemantia royleana seed gumBalangu seed mucilageLRSMBalangu polysaccharideLallemantia royleana seed mucilage

Beyond the preview

Go deeper on lallemantia royleana polysaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lallemantia royleana polysaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call